Individuals with cystic fibrosis or CFTR gene variants have a 3-fold higher risk of developing pancreatic cancer after 50 years of age.

Supporters are gearing up for two charity football games across Bristol in aid of the Cystic Fibrosis Comfort Fund. The first ...

BiomX has published promising phase 1b/2a trial results in Nature Communications, demonstrating that its phage cocktail BX004 ...

Vertex Pharmaceuticals said on Tuesday its next-generation cystic fibrosis treatment has won European Union approval for a ...

The biotech is taking inspiration from cystic fibrosis treatment and applying a similar approach to developing "corrector" and "potentiator" medicines for the kidney disease.

The prevalence of food allergy is significantly lower in children with cystic fibrosis than in those without the condition in ...

Premier research journal article provides validation for BiomX’s phage therapy platform, showcasing first-in-human Phase ...

With its blockbuster Trikafta set to lose patent protection within the decade, Vertex is strengthening its cystic fibrosis ...